Pharmaco - Press Releases

Date	Title	Company
23-Sep-2021	Takeda Selects Four New Partners for Annual Global Corporate Social Responsibility (CSR) Program to Help Strengthen Health Systems in Low- and Middle-Income Countries	Takeda
23-Sep-2021	Takeda Breaks Ground on its First Zero Energy Building in Singapore	Takeda
23-Sep-2021	Thermo Fisher Expands Capabilities with its Multichannel NanoDrop Eight UV-Vis Microvolume Spectrophotometer	Thermo Fisher Scientific
23-Sep-2021	Original-Research: Formycon (von First Berlin Equity Research GmbH)	Formycon
23-Sep-2021	Santhera and ReveraGen to Present Phase 2a/2b Efficacy and New Safety Data with Vamorolone at Forthcoming Conferences	Santhera and ReveraGen
23-Sep-2021	Santhera Completes Capital Increase for Financing Arrangements	Santhera
23-Sep-2021	77th Pharma Partnering Event Live Again!	RauCon
23-Sep-2021	ASLAN PHARMACEUTICALS TO PARTICIPATE IN THE 2021 CANTOR VIRTUAL GLOBAL HEALTHCARE CONFERENCE	ASLAN PHARMACEUTICALS
22-Sep-2021	ProductLife Group and Juuka Advisory team up to launch ProductLife Consulting	ProductLife Group and Juuka Advisory
22-Sep-2021	New Premises Support Tower’s Continuing Growth	Tower Cold Chain
22-Sep-2021	UK's PrivateDoc Manage Mysimba Medication Delays Caused by Brexit	PrivateDoc
22-Sep-2021	Clarity Pharma gets to grips with UDI implementation in the UK	Clarity Pharma
22-Sep-2021	Pfizer and BioNTech Expand Collaboration with U.S. to Provide 500 Million Additional COVID-19 Vaccine Doses at Not-For-Profit Price for Donation to Poorest Countries	Pfizer and BioNTech
22-Sep-2021	China based CMS joins BaseLaunch as latest partner	BaseLaunch
22-Sep-2021	Lilly announces procurement agreement with European Commission to supply bamlanivimab and etesevimab together for the treatment of confirmed COVID-19	Lilly
22-Sep-2021	Roche launches three respiratory test panels on cobas 6800/8800 Systems in CE markets to help identify multiple pathogens with overlapping symptoms in patients	Roche
22-Sep-2021	Theragnostics Announces Licensing Agreement for Development and Commercialization of One-Step PET Radiopharmaceuticals	Theragnostics
22-Sep-2021	Moberg Pharma receives approval from the EMA’s Paediatric Committee	Moberg Pharma
22-Sep-2021	Vetter's Contribution to Climate Protection: Corporate Sites Around the World are CO2-Neutral	Vetter
22-Sep-2021	PureTech Announces Publication of New Preclinical Research from Collaborators that Supports Mesenteric Lymphatic Dysfunction as a Potential Cause of and Therapeutic Target for Obesity and Insulin Resistance	PureTech